Engaging Clinical Champions to Improve HPV Vaccination

Engaging Clinical Champions to Improve HPV Vaccine Communication and Uptake in Healthcare Systems

This trial will compare two ways to improve communication about HPV vaccination in primary care. The research team will work with primary care clinics. Some clinics will receive communication training from an outside expert. Other clinics will receive the same training from a vaccine champion from their healthcare system.

The researchers will conduct a cluster randomized non-inferiority trial. The trial will compare two ways of delivering a communication workshop called Announcement Approach Training (AAT). AAT is designed to improve communication about HPV vaccination in primary care. The researchers will randomize clinics within participating healthcare systems. Some clinics will receive the training from an outside expert. Other clinics will receive the same training from a vaccine champion from their own system. The researchers will use medical record data to compare changes in HPV vaccination among children ages 9-12. Clinics will be followed for 12 months. The study will engage clinical staff. Researchers will not have direct contact with children or their families.

This trial will enroll clinics and intervene with clinical staff. We will use vaccination data from children to evaluate intervention effectiveness. We will not enroll children or interact with them directly.

Inclusion Criteria

Clinics are eligible if they:

• provide primary care to children ages 9-12
• specialize in pediatrics or family medicine

Children's medical records will be eligible to be included in the dataset if children:

• are between the ages of 9-12 years at baseline
• are attributed to a participating clinic at 12-month follow-up

Exclusion criteria

Clinics are excluded if they:

• do not provide primary care to children ages 9-12
• have a specialty other than pediatrics or family medicine

Children's medical records will be excluded if children:

• are not between the ages of 9-12 years at baseline
• are not attributed to a participating clinic at 12-month follow-up
• are receiving hospice/palliative care, are pregnant, or have a history of HPV vaccine contraindications